Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
Moving the needle in spinal fusion has never been easier
Speed and efficiency are essential in the operating room, which is why we created MagnetOsTM Easypack Putty to be ready-to-use, easy to mold, and designed to stay put.
It delivers all the benefits of our established MagnetOs family thanks to our unique NeedleGripTM surface technology – which grows bone even in soft tissue, without added cells or growth factors.*
Simply dispense MagnetOs Easypack Putty into your hand using the accompanying syringe, mold the product into the shape you need, and it’s ready to be implanted.
MagnetOs Easypack Putty meets your perioperative needs, leading to one thing: a more predictable fusion.†¶1,2
Ready-to-use
MagnetOs Easypack Putty comes ready-to-use in an open-ended syringe for instant application into the palm of your hand. No further preparation is needed – thus saving you (and your team) precious minutes in the operating room.
Easy to mold
Because of its unique thermo-sensitive polymer binder, MagnetOs Easypack Putty is easy to mold. This allows you to follow the contours of bony defects and fill those that are irregular in shape or size.
Designed to stay put
You don’t need to compromise on efficacy for the sake of perioperative performance. MagnetOs Easypack Putty has been formulated to resist irrigation during surgery and minimize post-operative graft migration.2 This is a putty that stays put.
Product code Volume (cc) Granule size (mm)
703-048-US 1.5 1-2
703-050-US 2.5 1-2
703-051-US 5 1-2
703-053-US 10 1-2
703-054-US 15 1-2
Want to learn more about MagnetOs Easypack Putty?
Book your own appointment with one of our scientific experts.
1. Van Dijk, et al. Clin Spine Surg. 2020;33(6):E276-E287.
2. Data on file.
* In large animal models.
† Results from in vitro or in vivo laboratory testing may not be predictive of clinical experience in humans. For important safety and intended use information please visit kurosbio.com.
¶ MagnetOs has been proven to generate more predictable fusions than two commercially available alternatives in an ovine model of posterolateral fusion.
PROMO/KUR/GL/062-21/R03